Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
10.95
+2.42 (28.37%)
At close: Oct 17, 2025, 4:00 PM EDT
9.15
-1.80 (-16.44%)
Pre-market: Oct 20, 2025, 5:00 AM EDT
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $8.51 million as of October 17, 2025. Its market cap has increased by 8.96% in one year.
Market Cap
8.51M
Enterprise Value
5.65M
1-Year Change
8.96%
Ranking
Category
Stock Price
$10.95
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $8.51M, a decrease of -97.37%. That is a compound annual growth rate of -17.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 8.51M | 37.22% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | 60.25M | 34.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.70B |
| Johnson & Johnson | 464.52B |
| AbbVie | 404.90B |
| UnitedHealth Group | 321.47B |
| AstraZeneca | 260.83B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 223.39B |